Table 5 Multivariate analysis of obtained results
Table 5 | p | OR | 95.0 % CI range |
|---|---|---|---|
The presence of heart failure | |||
Chronic kidney disease | 0,030 | 4,625 | (1,161 - 18,429) |
Osteopontin | 0,045 | 0,979 | (0.960 - 1,000) |
Age | 0,010 | 1,074 | (1,017 - 1,135) |
(independent of osteocalcin, osteoprotegerin, fetuin, gender) | |||
Age | 0,004 | 1,083 | (1,026 - 1,142) |
MMP-2 | 0,048 | 1,004 | (1,000 - 1,009) |
(independent of gender, chronic kidney disease, MMP-9, TIMP-1, TIMP-2) | |||
Age | 0,001 | 1,109 | (1,046 - 1,176) |
Chronic kidney disease | 0,038 | 5,361 | (1,098 - 26,176) |
(independent of gender, MGP, ANGII, chronic kidney disease) | |||
Age | 0,004 | 1,083 | (1,026 - 1,143) |
Chronic kidney disease | 0,013 | 7,449 | (1,532 - 36,222) |
AIP | 0,053 | 8,694 | (0,977 - 77,396) |
(independent of gender, ABCA1, ABCG1, non-HDL cholesterol, urea) | |||
Phosphates above normal level | |||
Osteoprotegerin | 0,025 | 1,163 | (1,019 - 1,328) |
(independent of osteocalcin, osteopontin, fetuin, age, gender) | |||
Presence of hypertension | |||
Chronic kidney disease | 0,007 | 8,202 | (1,790 - 37,584) |
(independent of age, gender, MMP-2, MMP-9, TIMP-1, TIMP-2) | |||
The presence of atherosclerosis | |||
Gender | 0,017 | 0,223 | (0,065 - 0,769) |
(independent of age, chronic kidney disease, MMP-2, MMP-9, TIMP-1, TIMP-2) | |||
Gender | 0,045 | 0,301 | (0,093 - 0,971) |
(independent of age, chronic kidney disease, MGP, GM-CSF, ANGII | |||
Lipid disorders | |||
Non-HDL cholesterol | 0,007 | 1,881 | (1,186 - 2,983) |
(independent of age, gender, chronic kidney disease, ABCA1, ABCG1, AIP, urea) | |||
AIP – high risk | |||
TCh | 0,000 | 0,019 | 0,003 – 0,138 |
Non-HDL cholesterol | 0,000 | 110,134 | 11,416 - 1062,535 |
(independent of age, gender, chronic kidney disease, ABCA1, ABCG1, urea) | |||